Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Transplantation of Autologous Stem Cells Into Pancreatic Artery, Combined With Immunomodulation for the Treatment of Type 1 Diabetes Mellitus

NCT02644759 is registered in ClinicalTrials.gov with Stem Cells Arabia as lead sponsor.

NCT NCT02644759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Transplantation of Autologous Stem Cells Into Pancreatic Artery, Combined With Immunomodulation for the Treatment of Type 1 Diabetes Mellitus
Lead sponsor
Stem Cells Arabia
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2014
Completion date
May 31, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, diabetes mellitus type 1, endocrine system diseases, glucose metabolism disorders, immune system diseases, metabolic diseases